| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |